Skip to content

Evaluation of prophylactic salpingectomy on ovarian function

Evaluation of prophylactic salpingectomy on ovarian function in patients undergo hysterectomy by laparascopic & laparatomy in Arash hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014123118866N4
Enrollment
40
Registered
2015-02-15
Start date
2014-11-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine bleeding. Irregular menstruation, unspecified

Interventions

Intervention 1: First group: the patient undergoes hysterectomy and salpangectomy. Intervention 2: Second group: the patient undergoes only hysterectomy.
Treatment - Surgery
First group: the patient undergoes hysterectomy and salpangectomy.
Second group: the patient undergoes only hysterectomy.

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women aged 18-45 years old, candidates for hysterectomy and not oopherectomy; no menopause symptoms; FSH<10 IU. Exclusion criteria: history of pelvic surgery; existence of ovarian mass in sonography before the surgery; smoking; OCP consumption at least for 6 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
FSH serum level. Timepoint: Before surgery and 3 moths after t. Method of measurement: Blood test.;Serum anti-mullerian hormone level. Timepoint: Before surgery and 3 months after it. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Roghieh Hasani

Tehran University of Medical Sciences

somayesaat_hidary@yahoo.com+98 21 7788 3283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 9, 2026